Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
Withdrawn

Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea

Min Seo Kim, Soon-Woo Jang, Yu-Kyung Park, Bong-Ok Kim, Tae-Ho Hwang, Seok Ho Kang, Won Jun Kim, Park Sung Kyu, Hea-Woon Park, Wonjong Yang, Joonyoung Jang, Min Ho An
doi: https://doi.org/10.1101/2020.05.13.20094193
Min Seo Kim
Cheongsan Public Health Center, Wando, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: minho.an23@gmail.com
Soon-Woo Jang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Kyung Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bong-Ok Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tae-Ho Hwang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seok Ho Kang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Won Jun Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Park Sung Kyu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hea-Woon Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wonjong Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joonyoung Jang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Ho An
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The authors have withdrawn this manuscript because of the controversy about hydroxychloroquine and potential changes in results after peer-review, the authors intend to share their results in formal publication. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No supported funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of Pusan National University Yangsan Hospital, Pusan, Korea approved this study and granted a waiver of informed consent from study participants

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

A retrospective cohort study of 358 patients with laboratory-confirmed SARS Cov 2 infection hospitalized in Korea Workers Compensation and Welfare Service Daegu Hospital was conducted

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 14, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
Min Seo Kim, Soon-Woo Jang, Yu-Kyung Park, Bong-Ok Kim, Tae-Ho Hwang, Seok Ho Kang, Won Jun Kim, Park Sung Kyu, Hea-Woon Park, Wonjong Yang, Joonyoung Jang, Min Ho An
medRxiv 2020.05.13.20094193; doi: https://doi.org/10.1101/2020.05.13.20094193
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
Min Seo Kim, Soon-Woo Jang, Yu-Kyung Park, Bong-Ok Kim, Tae-Ho Hwang, Seok Ho Kang, Won Jun Kim, Park Sung Kyu, Hea-Woon Park, Wonjong Yang, Joonyoung Jang, Min Ho An
medRxiv 2020.05.13.20094193; doi: https://doi.org/10.1101/2020.05.13.20094193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8987)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1958)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10808)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1903)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)